ICMR Chief raises safety concerns over anti-COVID pill Molnupiravir - Here's what he said

ICMR Chief raises safety concerns over anti-COVID pill Molnupiravir - Here's what he said

https://ift.tt/wEcZxH drug comes with warning that it cannot be used in patients less than 18 years or pregnant women. Contraception has to be maintained for 3 months.

donewssuper.blogspot.com DNA Web Team

0 Response to "ICMR Chief raises safety concerns over anti-COVID pill Molnupiravir - Here's what he said"

Post a Comment